Skip to Content

Month: January 2023

Registran un aumento rápido de los casos de la subvariante XBB.1.5 en todo el mundo, pero funcionarios de EE.UU. aún consideran que lo que sucede en China es ‘único’

Sofía Benavides (CNN) — La nueva subvariante XBB.1.5 de ómicron “pasó de ser casi inexistente hace un mes a representar ahora una gran parte de las infecciones totales” y está “aumentando rápidamente”, dijo este viernes el doctor Ashish Jha, coordinador de la respuesta de la Casa Blanca ante el covid-19. En una entrevista con Kate Bolduan

Continue Reading
The US Food and Drug Administration granted accelerated approval on January 6 for the Alzheimer's disease drug Lecanemab

Alzheimer’s drug lecanemab receives accelerated approval amid safety concerns

By Jacqueline Howard and Brenda Goodman, CNN The US Food and Drug Administration granted accelerated approval Friday for the Alzheimer’s disease drug lecanemab, one of the first experimental dementia drugs to appear to slow the progression of cognitive decline. “Alzheimer’s disease immeasurably incapacitates the lives of those who suffer from it and has devastating effects

Continue Reading
Skip to content